Literature DB >> 25200525

Reduced glucose utilization underlies seizure protection with dietary therapy in epileptic EL mice.

Joshua J Meidenbauer1, Mary F Roberts2.   

Abstract

Dietary therapy has been used to treat many individuals with epilepsy whose seizures are refractory to antiepileptic drugs. The mechanisms for how dietary therapy confers seizure protection are currently not well understood. We evaluated the acute effects of glucose and β-hydroxybutyrate (the major circulating ketone body) in conferring seizure protection to the EL mouse, a model of multifactorial idiopathic generalized epilepsy. EL mice were fed either an unrestricted standard diet or a calorie-restricted standard diet to achieve a body weight reduction of 20-23%. D-Glucose, 2-deoxy-D-glucose, and β-hydroxybutyrate were supplemented in the drinking water of calorie-restricted mice for 2.5 h prior to seizure testing to simulate the effect of increased glucose availability, decreased glucose utilization, and increased ketone availability, respectively. Seizure susceptibility, body weight, plasma glucose, and β-hydroxybutyrate were measured over a nine-week treatment period. Additionally, excitatory and inhibitory amino acids were measured in the brains of mice using (1)H NMR. Glutamate decarboxylase activity was also measured to evaluate the connection between dietary therapy and brain metabolism. We found that lowering of glucose utilization is necessary to confer seizure protection with long-term (>4 weeks) calorie restriction, whereas increased ketone availability did not affect seizure susceptibility. In the absence of long-term calorie restriction, however, reduced glucose utilization and increased ketone availability did not affect seizure susceptibility. Brain excitatory and inhibitory amino acid content did not change with treatment, and glutamate decarboxylase activity was not associated with seizure susceptibility. We demonstrated that reduced glucose utilization is necessary to confer seizure protection under long-term calorie restriction in EL mice, while acute ketone supplementation did not confer seizure protection. Further studies are needed to uncover the mechanisms by which glucose utilization influences seizure susceptibility.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2-Deoxy-d-glucose (2-DG); Calorie restriction; Epilepsy; Ketogenic diet; Ketone bodies

Mesh:

Substances:

Year:  2014        PMID: 25200525      PMCID: PMC4252783          DOI: 10.1016/j.yebeh.2014.08.007

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  39 in total

Review 1.  Rationale for using intermittent calorie restriction as a dietary treatment for drug resistant epilepsy.

Authors:  Alan W C Yuen; Josemir W Sander
Journal:  Epilepsy Behav       Date:  2014-03-18       Impact factor: 2.937

2.  Environmental risk factors for multifactorial epilepsy in EL mice.

Authors:  M T Todorova; T J Burwell; T N Seyfried
Journal:  Epilepsia       Date:  1999-12       Impact factor: 5.864

3.  The EL mouse: a natural model of autism and epilepsy.

Authors:  Joshua J Meidenbauer; John G Mantis; Thomas N Seyfried
Journal:  Epilepsia       Date:  2011-01-04       Impact factor: 5.864

4.  The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy.

Authors:  M T Todorova; P Tandon; R A Madore; C E Stafstrom; T N Seyfried
Journal:  Epilepsia       Date:  2000-08       Impact factor: 5.864

5.  Adaptation of an enzymatic fluorescence assay for L-glutamic acid decarboxylase.

Authors:  R Wolf; H Klemisch
Journal:  Anal Biochem       Date:  1991-01       Impact factor: 3.365

Review 6.  The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.

Authors:  Marwan Maalouf; Jong M Rho; Mark P Mattson
Journal:  Brain Res Rev       Date:  2008-09-25

7.  The inhibition of bovine heart hexokinase by 2-deoxy-D-glucose-6-phosphate: characterization by 31P NMR and metabolic implications.

Authors:  W Chen; M Guéron
Journal:  Biochimie       Date:  1992 Sep-Oct       Impact factor: 4.079

8.  Regional ketone body utilization by rat brain in starvation and diabetes.

Authors:  R A Hawkins; A M Mans; D W Davis
Journal:  Am J Physiol       Date:  1986-02

9.  The energetics of ion distribution: the origin of the resting electric potential of cells.

Authors:  Richard L Veech; Yoshihiro Kashiwaya; Denise N Gates; M Todd King; Kieran Clarke
Journal:  IUBMB Life       Date:  2002-11       Impact factor: 3.885

10.  Influence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL/6J mice.

Authors:  Joshua J Meidenbauer; Nathan Ta; Thomas N Seyfried
Journal:  Nutr Metab (Lond)       Date:  2014-05-22       Impact factor: 4.169

View more
  7 in total

Review 1.  Metabolism and epilepsy: Ketogenic diets as a homeostatic link.

Authors:  Susan A Masino; Jong M Rho
Journal:  Brain Res       Date:  2018-06-06       Impact factor: 3.252

2.  Therapeutic ketosis decreases methacholine hyperresponsiveness in mouse models of inherent obese asthma.

Authors:  Madeleine M Mank; Leah F Reed; Camille J Walton; Madison L T Barup; Jennifer L Ather; Matthew E Poynter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-12-22       Impact factor: 5.464

3.  Anticonvulsant effect of exogenous β-hydroxybutyrate on kainic acid-induced epilepsy.

Authors:  Jianping Si; Shaohui Wang; Ning Liu; Xiaofei Yang; Ying Wang; Ling Li; Jiwen Wang; Xin Lv
Journal:  Exp Ther Med       Date:  2017-06-07       Impact factor: 2.447

4.  Ketogenic diets improve behaviors associated with autism spectrum disorder in a sex-specific manner in the EL mouse.

Authors:  David N Ruskin; Jessica A Fortin; Subrina N Bisnauth; Susan A Masino
Journal:  Physiol Behav       Date:  2016-11-09

5.  Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy.

Authors:  Mumin Alper Erdogan; Dimas Yusuf; Joanna Christy; Volkan Solmaz; Arife Erdogan; Emin Taskiran; Oytun Erbas
Journal:  BMC Neurol       Date:  2018-06-07       Impact factor: 2.474

6.  Differential ketogenic diet-induced shift in CSF lipid/carbohydrate metabolome of pediatric epilepsy patients with optimal vs. no anticonvulsant response: a pilot study.

Authors:  Susan A Masino; David N Ruskin; Natalie R Freedgood; Marie Lindefeldt; Maria Dahlin
Journal:  Nutr Metab (Lond)       Date:  2021-03-01       Impact factor: 4.169

Review 7.  Dysregulated Glucose Metabolism as a Therapeutic Target to Reduce Post-traumatic Epilepsy.

Authors:  Jenny B Koenig; Chris G Dulla
Journal:  Front Cell Neurosci       Date:  2018-10-16       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.